Evidence map›Paper›PMID 32228863›Full record

ArticleeLife2020

TMEM87a/Elkin1, a component of a novel mechanoelectrical transduction pathway, modulates melanoma adhesion and migration.

Amrutha Patkunarajah, Jeffrey H Stear, Mirko Moroni, Lioba Schroeter, Jedrzej Blaszkiewicz, Jacqueline LE Tearle, Charles D Cox, Carina Fürst, Oscar Sánchez-Carranza, María Del Ángel Ocaña Fernández and 7 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Piezo1-related physiological and pathological processes in glioblastoma.Frontiers in cell and developmental biology · 2025
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Amrutha Patkunarajah *EMBL Australia Node in Single Molecule Science, School of Medical Sciences, University of New South Wales, Sydney, Australia.
Jeffrey H Stear *EMBL Australia Node in Single Molecule Science, School of Medical Sciences, University of New South Wales, Sydney, Australia.
Mirko MoroniMax Delbrück Center for Molecular Medicine, Berlin-Buch, Germany.
Lioba SchroeterEMBL Australia Node in Single Molecule Science, School of Medical Sciences, University of New South Wales, Sydney, Australia.
Jedrzej BlaszkiewiczMax Delbrück Center for Molecular Medicine, Berlin-Buch, Germany.
Jacqueline LE TearleEMBL Australia Node in Single Molecule Science, School of Medical Sciences, University of New South Wales, Sydney, Australia.
Charles D CoxVictor Chang Cardiac Research Institute, Sydney, Australia.
Carina FürstMax Delbrück Center for Molecular Medicine, Berlin-Buch, Germany.
Oscar Sánchez-CarranzaMax Delbrück Center for Molecular Medicine, Berlin-Buch, Germany.
María Del Ángel Ocaña FernándezMax Delbrück Center for Molecular Medicine, Berlin-Buch, Germany.
Raluca FleischerMax Delbrück Center for Molecular Medicine, Berlin-Buch, Germany.
Murat EravciFreie Universität Berlin, Institute of Chemistry and Biochemistry, Berlin, Germany.
Christoph WeiseFreie Universität Berlin, Institute of Chemistry and Biochemistry, Berlin, Germany.
Boris MartinacVictor Chang Cardiac Research Institute, Sydney, Australia.ORCID 0000-0001-8422-7082
Maté BiroEMBL Australia Node in Single Molecule Science, School of Medical Sciences, University of New South Wales, Sydney, Australia.ORCID 0000-0001-5852-3726
Gary R LewinMax Delbrück Center for Molecular Medicine, Berlin-Buch, Germany.ORCID 0000-0002-2890-6352
Kate PooleEMBL Australia Node in Single Molecule Science, School of Medical Sciences, University of New South Wales, Sydney, Australia.ORCID 0000-0003-0879-6093
Max Delbrück Center · DEUNSW Sydney · AUFreie Universität Berlin · DEVictor Chang Cardiac Research Institute · AU

Funding

Deutsche Forschungsgemeinschaft SFB958, A09Deutsche Forschungsgemeinschaft SFB958, Z03National Health and Medical Research Council APP1135974National Health and Medical Research Council APP1138595
6 · The paper itself

Abstract

Mechanoelectrical transduction is a cellular signalling pathway where physical stimuli are converted into electro-chemical signals by mechanically activated ion channels. We describe here the presence of mechanically activated currents in melanoma cells that are dependent on TMEM87a, which we have renamed Elkin1. Heterologous expression of this protein in PIEZO1-deficient cells, that exhibit no baseline mechanosensitivity, is sufficient to reconstitute mechanically activated currents. Melanoma cells lacking functional Elkin1 exhibit defective mechanoelectrical transduction, decreased motility and increased dissociation from organotypic spheroids. By analysing cell adhesion properties, we demonstrate that Elkin1 deletion is associated with increased cell-substrate adhesion and decreased homotypic cell-cell adhesion strength. We therefore conclude that Elkin1 supports a PIEZO1-independent mechanoelectrical transduction pathway and modulates cellular adhesions and regulates melanoma cell migration and cell-cell interactions.

Indexed as

Cell AdhesionCell CommunicationCell Line, TumorCell MovementHumansIon ChannelsMechanotransduction, CellularMelanomaMembrane ProteinsSpheroids, CellularIon ChannelsMembrane ProteinsPIEZO1 protein, humancancer biologycell adhesioncell biologycell migrationhumanmechanically activated ion channelsmechanotransductionmelanoma

Identifiers

PMID32228863
PMCPMC7173973
OpenAlexW3013440198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.